Division of Sleep Medicine, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA.
Division of Sleep Surgery, Department of Otolaryngology-Head & Neck Surgery, School of Medicine, Stanford University, Stanford, CA, USA.
Sleep Med. 2022 Apr;92:96-102. doi: 10.1016/j.sleep.2022.02.011. Epub 2022 Feb 19.
Adenoid and tonsillar hypertrophy in children often leads to adverse respiratory symptoms and obstructive sleep apnea (OSA). Current clinical guidelines from the American Academy of Pediatrics and American Academy of Otolaryngology-Head and Neck Surgery recommend tonsillectomy as the first line of pediatric OSA treatment for children with tonsillar hypertrophy. Rapid palatal expansion (RPE) performed by orthodontists improves obstructive sleep apnea in children by reducing nasal airway resistance, increasing nasal volume, raising tongue posture, and enlarging pharyngeal airway. However, the role of RPE in alleviating adenoid and tonsillar hypertrophy remains elusive. In this study, we aim to evaluate the changes in adenoid and palatine tonsil sizes following RPE using 3D volumetric analysis of cone beam computational tomography (CBCT) imaging.
In this retrospective cohort study, a total of 60 pediatric patients (mean age: 8.00, range: 5-15, 32 females and 28 males) who had tonsillar hypertrophy (size 3 and 4) were included and divided into the control group (n = 20) and expansion group (n = 40). The control group did not undergo any treatment. The expansion group underwent RPE using a conventional Hyrax expander, activated 0.25 mm per day for 4-6 weeks. Final CBCT scans (T2) were performed 13.8 ± 6.5 months after the initial scan (T1). Pediatric sleep questionnaire (PSQ) and BMI were obtained at each timepoint. Volumetric analysis of adenoid and palatine tonsils was performed using a combination of bony and soft tissue landmarks in CBCT scans through Anatomage Invivo 6 imaging software. Paired t-tests were used to evaluate the difference between the initial and final adenoid and tonsil volumes. p values less than 0.05 were considered statistically significant.
Compared to the control group, the expansion group experienced a statistically significant decrease in both adenoid and tonsil volume. There was non-statistically significant increase in volume from T1 to T2 for the control group. For the expansion group, 90.0% and 97.5% of patients experienced significant reduction in adenoid and tonsil volume, respectively. The average volume decrease of adenoids was 16.8% while that of tonsils was 38.5%. The patients had up to 51.6% and 75.4% reduction in adenoid and tonsil size, respectively, following RPE orthodontic treatment. Pearson correlation ranged from 0.88 to 0.99 for each measurement, representing excellent internal consistency. There was a significant reduction in the PSQ scores from 5.81 ± 3.31 to 3.75 ± 2.38 in expansion group (p < 0.001).
Our results demonstrated that RPE significantly reduced the size of both adenoid and palatine tonsils and revealed another long-term benefit of RPE treatment. To our knowledge, this is the first study to quantify the changes of adenoids and tonsils following RPE. RPE treatment can be considered as a valid and effective treatment option for pediatric OSA population with narrow high arch palate and adenotonsillar hypertrophy.
儿童腺样体和扁桃体肥大常导致不良呼吸症状和阻塞性睡眠呼吸暂停(OSA)。美国儿科学会和美国耳鼻喉头颈外科学会的现行临床指南建议,对于扁桃体肥大的儿童,扁桃体切除术是治疗儿童 OSA 的一线治疗方法。正畸医生进行的快速腭扩张(RPE)通过降低鼻腔气道阻力、增加鼻腔容积、提高舌位和扩大咽气道来改善儿童 OSA。然而,RPE 缓解腺样体和扁桃体肥大的作用仍不清楚。在这项研究中,我们旨在通过锥形束计算机断层扫描(CBCT)成像的三维容积分析来评估 RPE 后腺样体和腭扁桃体大小的变化。
在这项回顾性队列研究中,共纳入 60 名患有扁桃体肥大(大小为 3 和 4)的儿科患者(平均年龄:8.00 岁,范围:5-15 岁,32 名女性和 28 名男性),并分为对照组(n=20)和扩张组(n=40)。对照组未接受任何治疗。扩张组使用常规 Hyrax 扩张器进行 RPE,每天激活 0.25mm,持续 4-6 周。初始扫描(T1)后 13.8±6.5 个月进行最终 CBCT 扫描(T2)。在每个时间点均获得小儿睡眠问卷(PSQ)和 BMI。通过 Anatomage Invivo 6 成像软件,在 CBCT 扫描中使用骨性和软组织标志的组合对腺样体和腭扁桃体进行容积分析。使用配对 t 检验评估初始和最终腺样体和扁桃体体积之间的差异。p 值小于 0.05 被认为具有统计学意义。
与对照组相比,扩张组的腺样体和扁桃体体积均有统计学显著降低。对照组从 T1 到 T2 的体积有非统计学显著增加。对于扩张组,90.0%和 97.5%的患者的腺样体和扁桃体体积分别有显著减少。腺样体的平均体积减少 16.8%,而扁桃体的平均体积减少 38.5%。接受 RPE 正畸治疗后,患者的腺样体和扁桃体大小分别减少了 51.6%和 75.4%。Pearson 相关系数在每个测量值中均为 0.88 至 0.99,代表良好的内部一致性。扩张组的 PSQ 评分从 5.81±3.31 显著降低至 3.75±2.38(p<0.001)。
我们的结果表明,RPE 显著缩小了腺样体和腭扁桃体的大小,并揭示了 RPE 治疗的另一个长期益处。据我们所知,这是第一项定量研究 RPE 后腺样体和扁桃体变化的研究。RPE 治疗可被视为治疗高拱腭狭窄和腺样体扁桃体肥大的儿童 OSA 人群的有效治疗选择。